Dopo l'orario di chiusura: 18.46

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie

Rocket Pharmaceuticals Inc [RCKT] Records 50-Day SMA of $20.33 - Knox Daily

Maverick Capital Ltd. Acquires 40,000 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Profund Advisors LLC Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 3.9% - Defense World

A significant driver of top-line growth: Rocket Pharmaceuticals Inc (RCKT) - SETE News

Rocket Pharmaceuticals Inc (RCKT) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Logos Global Management LP Has $7.54 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.7% - Defense World

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.7% - MarketBeat

Insider’s View: Deciphering Rocket Pharmaceuticals Inc (RCKT)’s Financial Health Through Ratios - The Dwinnex

Should investors be concerned about Rocket Pharmaceuticals Inc (RCKT)? - US Post News

RCKT (Rocket Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Victory Capital Management Inc. - MarketBeat

Will Rocket Pharmaceuticals (NASDAQ:RCKT) Spend Its Cash Wisely? - Simply Wall St

Blair William & Co. IL Has $3.07 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

(RCKT) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Rocket Pharmaceuticals Inc [RCKT] insider makes an insider purchase of 1,064 shares worth 19688.0. - Knox Daily

Rocket Stock Down More Than 30% in Past Six Months: Here's Why - MSN

Contrasting Rocket Pharmaceuticals (NASDAQ:RCKT) & Guardion Health Sciences (NASDAQ:GHSI) - Defense World

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Rocket: Danon Disease Treatment Program Should Carry The Tide Until Regulatory Moves - Seeking Alpha

Renaissance Technologies LLC Raises Stock Holdings in Rocket Companies, Inc. (NYSE:RKT) - Defense World

Rocket Companies Inc [RKT] Shares Jump Approximately 120.76% Over the Year - Knox Daily

Canaccord maintains Buy rating on Rocket Pharma, with consistent price target - Investing.com Canada

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.5% - Defense World

Rocket Companies stock soars to 52-week high of $21.3 - Investing.com

Rocket Cos. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Rocket Companies (NYSE:RKT) Sets New 1-Year High at $21.38 - Defense World

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 3.5% - MarketBeat

Rocket Pharmaceuticals Inc (RCKT) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Rocket Pharmaceuticals Inc (RCKT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Canaccord maintains Buy rating on Rocket Pharma, with consistent price target - Investing.com UK

RCKT Completes Enrollment in Rare Heart Disease Study, Stock Rises - Zacks Investment Research

Did Rocket Companies Inc (RKT) perform well in the last session? - US Post News

Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks

Rocket Pharmaceuticals’ (RCKT) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Rocket Pharmaceuticals completes enrollment for Danon disease trial - Investing.com

Morgan Stanley maintains Overweight rating on Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 6.4% Higher - MarketBeat

Rocket Cos. Inc. stock outperforms competitors on strong trading day - MarketWatch

Ratio Review: Analyzing Rocket Pharmaceuticals Inc (RCKT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Rocket Pharma stock gains on trial update (NASDAQ:RCKT) - Seeking Alpha

Perhaps timely catching Rocket Companies Inc (RKT) would be a good idea - SETE News

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Rating Reaffirmed by Needham & Company LLC - MarketBeat

Rocket Companies: Sky-High Hopes, Grounded Reality (NYSE:RKT) - Seeking Alpha

Rocket Pharmaceuticals completes enrollment for Danon disease trial - Investing.com India

Rocket Pharmaceuticals: All patients enrolled in RP-A501 study to treat Danon - TipRanks

Rocket Pharmaceuticals completes enrollment for Danon disease trial By Investing.com - Investing.com Australia

Rocket Pharmaceuticals completes enrollment for Danon disease trial By Investing.com - Investing.com Canada

Morgan Stanley on Rocket Pharmaceuticals (RCKT): 'we are encouraged by rapid enrollment' - StreetInsider.com

Rocket Pharmaceuticals completes enrollment for Danon disease trial By Investing.com - Investing.com UK

Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease - StockTitan

Investing in Rocket Pharmaceuticals Inc (RCKT) Is Getting More Attractive - Knox Daily

Rocket Pharmaceuticals: 2 Gene Therapy Candidates Anticipating Near-Term Review - Seeking Alpha

Rocket Companies, Inc. (NYSE:RKT) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by First Turn Management LLC - MarketBeat

Rocket Companies (NYSE:RKT) PT Raised to $18.00 at Wedbush - Defense World

Royal Bank of Canada Increases Rocket Companies (NYSE:RKT) Price Target to $20.00 - Defense World

Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia

Rocket Pharmaceuticals appoints new board member - Investing.com

Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada

Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com UK

Rocket Pharmaceuticals Inc (RCKT)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Long Term Trading Analysis for (RCKT) - Stock Traders Daily

A Guide To The Risks Of Investing In Rocket Pharmaceuticals Inc (RCKT) - Knox Daily

Rocket Pharma adds Pfizer R&D head to board By Investing.com - Investing.com Canada

Rocket Pharma adds Pfizer R&D head to board - Investing.com

Rocket Pharma adds Pfizer R&D head to board By Investing.com - Investing.com UK

Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors - StockTitan

Simile a RCKT